Last reviewed · How we verify
NCT03950258
Endovascular Management of Pediatric Intracranial Arteriovenous Shunts
NA trial testing endovascular embolization in Arteriovenous Malformations in 40 participants. Completed in 5 May 2020.
5 May 2020
Quick facts
| Lead sponsor | Assiut University |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 40 |
| Start date | 1 July 2019 |
| Primary completion | 5 May 2020 |
| Estimated completion | 5 May 2020 |
| Sites | 1 location across Egypt |
Drugs / interventions tested
- endovascular embolization
Conditions studied
- Arteriovenous Malformations — all drugs for Arteriovenous Malformations →
- Arteriovenous Fistula — all drugs for Arteriovenous Fistula →
Sponsor
Assiut University
Who can join
Under 18, any sex, with Arteriovenous Malformations or Arteriovenous Fistula. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
* Review the outcomes of the Endovascular management of pediatric intracranial arteriovenous shunts. * Give an effective treatment for pediatric intracranial arteriovenous shunts and can detect the best method could be used and assess safety and efficacy of different endovascular techniques in treatment of different AV shunts. * Improve the outcome of these patients and decease rate of recurrence and complications.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03950258
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Arteriovenous Malformations
Currently open trials in the same condition.
- NCT05477680 — Intraoperative Brain Shift Calculation Study · NA · recruiting
- NCT05484245 — Sonography-guided Resection of Brain Mass Lesions · NA · recruiting
- NCT02879071 — Long Term Follow-up After Embolization of Brain Arteriovenous Malformations · recruiting
Other Assiut University trials
Trials by the same sponsor.
- NCT07423312 — Lead Exposure and Multiple Sclerosis · not yet recruiting
- NCT07234526 — Usage of Glucose Fluctuations as a Prognostic Marker in Septic Shock Patients · not yet recruiting
- NCT07273214 — Knowledge, Attitude and Practice of Third Trimester Pregnant Mothers Towards Self-Medication in Assiut, Egypt · not yet recruiting
- NCT07194863 — Efficacy of Essential Phospholipid Versus Betaine HCL/L-Glutamic Acid in MAFLD · not yet recruiting
- NCT07053709 — Screening for Hyperuricemia in Patients With Metabolic Associated Fatty Liver Disease (MAFLD) · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03950258 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Assiut University
- Last refreshed: 13 May 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03950258.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing